Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02358967 · ClinicalTrials.gov registry record · NA
Palm Tocotrienols in Chronic Hemodialysis (USA)
A NA study of Chronic Kidney Disease and End Stage Renal Disease, sponsored by Wayne State University.
- Completed
- Registry status
- NA
- Development phase
- 280
- Enrollment target
- 1
- Study location
NCT02358967 is a NA study of Chronic Kidney Disease and End Stage Renal Disease that has completed, run by Wayne State University. The registered enrollment target is 280 participants, below the 3,204-participant average among 101 other Chronic Kidney Disease trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02358967, a NA study of Chronic Kidney Disease and End Stage Renal Disease, has completed, sponsored by Wayne State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 280 participants
- Enrollment target
- 1
- Study location
Study Summary
Patients undergoing chronic hemodialysis are at increased risk for cardiovascular disease, attributed in part to increased oxidative stress, inflammation and dyslipidemia. Intervention with a naturally occurring dietary supplement may improve certain biomarkers of inflammation and oxidative stress and improve the lipid profile.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT TRF (Tocotrienol-rich-fraction)
Study Locations (1)
Michigan
- Wayne State University - Detroit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 280 participants |
| Start Date | 2017-06-15 |
| Est. Completion | 2020-08-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02358967
The ClinicalTrials.gov registry entry for NCT02358967 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 280 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,204-participant average among 101 other Chronic Kidney Disease trials with a reported enrollment target (91% lower). The listed sponsor is Wayne State University, which has 163 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Chronic Kidney Disease appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT02358967 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.
Frequently Asked Questions
What is clinical trial NCT02358967 about?
NCT02358967 is a clinical study titled "Palm Tocotrienols in Chronic Hemodialysis (USA)". Patients undergoing chronic hemodialysis are at increased risk for cardiovascular disease, attributed in part to increased oxidative stress, inflammation and dyslipidemia. Intervention with a naturally occurring dietary supplement may improve certain biomarkers of inflammation and oxidative stress a...
What is the current status of trial NCT02358967?
This trial is currently completed. It is a NA study. The enrollment target is 280 participants. The study started on 2017-06-15. Estimated completion is 2020-08-31.
What conditions does trial NCT02358967 study?
This clinical trial studies the following conditions: Chronic Kidney Disease, End Stage Renal Disease.
What interventions are being tested in trial NCT02358967?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), TRF (Tocotrienol-rich-fraction) (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02358967?
This trial is sponsored by Wayne State University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02358967 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Kidney Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Pivotal Study of the Velocity™ pAVF System
RECRUITING · NA
-
Intensive Patient Referral and Education Program Prior to Renal Replacement Therapy
RECRUITING · NA
-
A Stakeholder-enhanced Intervention to Improve the Decisional Partnership of Chronic Kidney Disease Dyads (IMPART)
RECRUITING · NA
-
Transforming Hemodialysis-Related Vascular Access Education
RECRUITING · NA
-
Transcutaneous Auricular Vagus Nerve Stimulation Device in CKD Population
RECRUITING · NA
-
Staged Kidney Transplantation During Combined Heart/Kidney Transplantation
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.